About Compound
Contrarian n-of-1 investor across AI/ML, robotics, bio and crypto, incubating scientific white-space early-phase companies, publishing hundreds of open technical theses and timing contrarian deployment using hedge-fund volatility and scientific expertise. With a disciplined investment approach, the team drives value for both founders and investors.

